News > Press Releases > Five Star Equities Issues New Research Reports... Five Star Equities Issues New Research Reports on GALE, OMER, REGN and ZIOP OMER, REGN, ZIOP, GALE | 1 day ago Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports. Galena Biopharma Inc. (NASDAQ: GALE) shares jumped 9.62 percent to close at $2.28 a share Monday. The stock traded between $2.13 and $2.31 volume of 9.49 million shares traded. The company recently presented a corporate update at the 20th Annual NewsMakers in the Biotech Industry Conference on Friday, September 27th. Get more information on Galena Biopharma and free access to the in-depth equity report at: www.FiveStarEquities.com/GALE Omeros Corporation (NASDAQ: OMER) shares declined 1.12 percent to close at $9.75 a share Monday. The stock traded between $9.50 and $10.70 on volume of 2.26 million shares traded. The company announced that the FDA has granted Orphan Drug Designation to Omeros’ OMS824 for the treatment of Huntington's disease. Shares of Omeros have gained approximately 120.0 percent year-to-date. Get more information on Omeros and free access to the in-depth equity report at: www.FiveStarEquities.com/OMER Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) shares increased 2.36 percent to close at $312.87 a share Monday. The stock traded between $301.97 and $319.83 on volume of 1.14 million shares traded. Piper Jaffray has raised its price target on the company to $360.00 from $336.00. Shares of Regeneron Pharmaceuticals Resources have gained approximately 82.0 percent year-to-date. Get more information on Regeneron Pharmaceuticals and free access to the in-depth equity report at: www.FiveStarEquities.com/REGN ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) shares spiked 8.84 percent to close at $3.94 a share Monday. The stock traded between $3.62 and $4.19 on volume of 3.35 million shares traded. The company recently presented at the “BioCentury's NewsMakers in the Biotech Industry Conference” on Friday, September 27th. Get more information on ZIOPHARM Oncology free access to the in-depth equity report at: www.FiveStarEquities.com/ZIOP Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release. Contact: Five Star Equities info@fivestarequities.com Accesswire IA October 1, 2013 - 8:41 AM EDT Tags: BIOTECHNOLOGY Rate this article v Add to favourites 0 Share0 Tweet0 Share0 Comments No comments yet. Be first to comment! Leave a Message Subscribe to comments for this article Enter security code: Related News Canadian Solar (CSIQ) delivers two energy plants to TransCanada (T.TRP) 25 minutes ago OIL & GAS MIDSTREAM | SOLAR India considers investing in Canadian pipeline projects 30 minutes ago Stockhouse @ the Bell: Stocks fall on Blackberry (T.BB), U.S. shutdown latest 46 minutes ago COMMUNICATION EQUIPMENT | AUTO MANUFACTURERS Recent U.S. Press Releases White Cloud Announces 5-Year Anniversary 16 minutes ago Timeshare Software Company TrackResults to Attend AOCAP Conference in Hong Kong 17 minutes ago Intermolecular Names Semiconductor Industry Veteran Rick Neely CFO 20 minutes ago SEMICONDUCTOR EQUIPMENT & MATERIALS More Press Releases » Read Shared Discussed Chrysler plans to go public in IPO, Detroit offers GM incentives 2 days ago AUTO MANUFACTURERS First Nations accuse BC of violating int'l law by issuing Enbridge (T.ENB) permits 2 days ago OIL & GAS MIDSTREAM InvestorsGuru.com 41 Filtered Mid-Day Market Movers Recap 4 days ago INDUSTRIAL METALS & MINERALS | GOLD | OIL & GAS E&P | BIOTECHNOLOGY | SOFTWARE - APPLICATION Athabasca Oil (T.ATH) up 8.8%: Canadian market movers 5 days ago GOLD | OIL & GAS E&P Barkerville Gold Mines (V.BGM) strikes gold loan deal with Eric Sprott 6 days ago GOLD Sponsored News Links $13,000 in prizes to be won! Register now for Horizons ETFs Biggest Winner Trading Competition! Turning Hard Times Into Good Times 2,000-tonnes-per-day Mill Throughput for Trevali’s Santander Mine $3.5 billion earmarked by United Nations to remediate Oil Lakes – CORRE (V.CVR) pre-qualified 23.72 Meters Of 5.09 g/t Gold At Martha Ellen as drilling continues Follow us on Read more at http://www.stockhouse.com/News/Press-Releases/2013/10/01/Five-Star-Equities-Issues-New-Research-Reports-on-GALE-OMER-REGN-and-ZIOP#teZpQxZfWIG9eWCu.99